A review of phase III clinical trials of US  FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis

Immunotherapy,Volume 14, Issue 8, Page 655-662, June 2022.

Source: Immunotherapy - May 5, 2022 Category: Allergy & Immunology Authors: Matthew J Lelegren Sam Y Son Joseph K Han Kent K Lam Source Type: research